ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Corporate Action, IR, Issuance, Listing Regulation, News, Regulatory, Shares, Swedish
November 18, 2024
29 Dec 2021

Acarix genomför riktad nyemission av aktier till garanter i samband med avslutad företrädesemission

Press release Malmö, 29 december, 2021 Acarix genomför riktad nyemission av aktier till garanter i samband med avslutad f&o...
Continue reading
author-avatar acarix
Corporate Action, English, IR, Issuance, Listing Regulation, News, Regulatory, Shares
November 18, 2024
20 Dec 2021

Acarix announce final outcome in rights issue

Press release Malmö, December 20, 2021 Acarix announce final outcome in rights issue Acarix AB ("Acarix" or the "Company") has c...
Continue reading
author-avatar acarix
Corporate Action, IR, Issuance, Listing Regulation, News, Regulatory, Shares, Swedish
November 18, 2024
20 Dec 2021

Acarix offentliggör slutgiltigt utfall i företrädesemission

Press release Malmö, 20 december, 2021 Acarix offentliggör slutgiltigt utfall i företrädesemission Acarix AB ("A...
Continue reading
author-avatar acarix
Corporate Action, IR, Listing Regulation, News, Prospectus, Regulatory, Swedish
November 18, 2024
30 Nov 2021

Acarix offentliggör prospekt i samband med företrädesemission om cirka 79 MSEK

Acarix offentliggör prospekt i samband med företrädesemission om cirka 79 MSEK Extra bolagsstämman i Acarix AB ("A...
Continue reading
author-avatar acarix
Corporate Action, English, IR, Listing Regulation, News, Prospectus, Regulatory
November 18, 2024
30 Nov 2021

Acarix publishes prospectus in connection with rights issue of approximately SEK 79 million

Acarix publishes prospectus in connection with rights issue of approximately SEK 79 million The Extraordinary General Meeting of Acari...
Continue reading
author-avatar acarix
Corporate Action, English, IR, Issuance, MAR, News, Regulatory, Shares
November 18, 2024
05 Nov 2021

Acarix decides on a fully guaranteed rights issue of approximately SEK 79,3 million to expand on the US market

Press release (MAR) Malmö, Sweden, November 5, 2021 Acarix decides on a fully guaranteed rights issue of approximately SEK 79,3 ...
Continue reading
author-avatar acarix
Corporate Action, IR, Issuance, MAR, News, Regulatory, Shares, Swedish
November 18, 2024
05 Nov 2021

Acarix beslutar om en fullt garanterad företrädesemission om cirka 79,3 MSEK för att expandera på USA-marknaden

Pressrelease (MAR) Malmö, 5 november, 2021 Acarix beslutar om en fullt garanterad företrädesemission om cirka 79,3 MSE...
Continue reading
author-avatar acarix
Corporate Action, English, IR, Issuance, Listing Regulation, News, Regulatory, Shares
November 18, 2024
29 Sep 2020

Acarix carries out a directed issue of shares to guarantors in conjunction with the oversubscribed rights issue

Press release Malmö, Sweden September 29, 2020 Acarix carries out a directed issue of shares to guarantors in conjunction with th...
Continue reading
author-avatar acarix
Corporate Action, IR, Issuance, Listing Regulation, News, Regulatory, Shares, Swedish
November 18, 2024
29 Sep 2020

Acarix genomför riktad nyemission av aktier till garanter i samband med den övertecknade företrädesemissionen

Pressmeddelande Malmö, Sverige, 29 september 2020 Acarix genomför riktad nyemission av aktier till garanter i samband med de...
Continue reading
author-avatar acarix
Corporate Action, IR, Listing Regulation, News, Other, Regulatory, Swedish
November 18, 2024
28 Sep 2020

Sista dag för handel med BTA

Pressmeddelande Malmö, Sverige, 28 september 2020 Sista dag för handel med BTA Sista dag för handel med Acarix AB:s (&...
Continue reading
author-avatar acarix
Corporate Action, English, IR, Listing Regulation, News, Other, Regulatory
November 18, 2024
28 Sep 2020

Last day of trading in paid subscribed shares (Sw. BTA)

Press release Malmö, Sweden September 28, 2020 Last day of trading in paid subscribed shares (Sw. BTA) Last day of trading in su...
Continue reading
author-avatar acarix
Corporate Action, English, IR, Issuance, Listing Regulation, News, Regulatory, Shares
November 18, 2024
11 Sep 2020

Acarix announce final outcome in oversubscribed rights issue

Press release Malmö, Sweden September 11, 2020 Acarix announce final outcome in oversubscribed rights issue Acarix AB ("Acarix"...
Continue reading
  • «
  • ‹
  • 2
  • 3
  • 4
  • 5
  • 6
  • ›
  • »
Acarix AB
Jungmansgatan 12
211 19 Malmö
SE
info@acarix.com

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V5

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.